Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Emmessar Biotech & Nutrition Ltd (NSE: EMMESSA), ISIN INE634B01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
EMMESSA last traded at ₹23.99 (+12.00%), with a 52-week range of ₹18.42 to ₹33.38 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 59.53%, FIIs 0.00%, DIIs 0.19%, mutual funds 0.05%.
EquiSense Score (ECS): 42/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.